Loading
VC
Vystar Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Stone Bryan Lawrence, was filed 10 Jul 2019.
Vystar Corp: what insiders have been doing
Vystar Corp belongs to the Chemicals & Materials sector. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Vystar Corp in twelve months, the latest record being from 15 August 2022.
The full history, which starts in 2009, counts 300 purchases against 37 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 54,821 USD and net income at -1.5 m USD.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
514
Thresholds
n/a
Buy Volume
€1M
300 ops. · all time
Sell Volume
€179,006
37 ops. · all time
Since the insiders bought
- -43.2%Entry US$3.90 · Close at T+365 US$2.21
- -86.2%Entry US$6.18 · Close at T+365 US$0.85
- -86.2%Entry US$5.80 · Close at T+365 US$0.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.07
Analyst consensus
Income statement
RevenueUS$54.8k
Gross profitUS$31.8k58% margin
EBITDA-US$1.1M-1933% margin
Net income-US$1.5M-2793.9% margin
Valuation
Beta-11.92
Balance sheet & cash
Market capUS$1.8M
Total debtUS$1M
Free Cash Flow-US$180.4k
Profitability & ownership
ROA-106.5%
% insiders7.0%
% institutions0.0%
Last declaration on 15 August 2022
Declarations514 total
590,000 shares0CommonSEC:0001493152-22-023075:1
750,000 shares0CommonSEC:0001493152-22-023075:2
166,000 shares0CommonSEC:0001493152-22-023075:3
500,000 shares@ US$0.003985.1% of flowCommonSEC:0001493152-22-023075:0
250,000 shares@ US$0.0078.2% of flowCommonSEC:0001493152-22-005382:3
100,000 shares@ US$0.0073.3% of flowCommonSEC:0001493152-22-005382:1
160,000 shares@ US$0.0075.3% of flowCommonSEC:0001493152-22-005382:2
50,000 shares@ US$0.00713.7% of flowCommonSEC:0001493152-22-005382:0
147,500 shares@ US$0.01310.7% of flowCommonSEC:0001493152-21-028518:1
100,000 shares@ US$0.0137.2% of flowCommonSEC:0001493152-21-028518:2
165,000 shares@ US$0.01110.1% of flowCommonSEC:0001493152-21-028518:3
300,000 shares@ US$0.01118.5% of flowCommonSEC:0001493152-21-028518:4
235,000 shares@ US$0.01114.4% of flowCommonSEC:0001493152-21-028518:5
150,000 shares@ US$0.0119.2% of flowCommonSEC:0001493152-21-028518:6
250,000 shares@ US$0.01115.4% of flowCommonSEC:0001493152-21-028518:7
2,500 shares@ US$0.0131.3% of flowCommonSEC:0001493152-21-028518:0
174,000 shares@ US$0.0150.3% of flowCommonSEC:0001493152-21-025326:1
138,300 shares@ US$0.0150.2% of flowCommonSEC:0001493152-21-025326:2
10,499 shares@ US$0.0150.9% of flowCommonSEC:0001493152-21-025326:0
250,000 shares@ US$0.0160.4% of flowCommonSEC:0001493152-21-025046:1
29,421 shares@ US$0.0170.1% of flowCommonSEC:0001493152-21-025046:2
250,000 shares@ US$0.01522.4% of flowCommonSEC:0001493152-21-025046:0
67,679 shares@ US$0.0180.1% of flowCommonSEC:0001493152-21-024782:1
200,000 shares@ US$0.0160.3% of flowCommonSEC:0001493152-21-024782:2
250,000 shares@ US$0.0160.4% of flowCommonSEC:0001493152-21-024782:3
25 of 514 declarations
About Vystar Corp
Vystar Corp. is a U.S.-listed company trading on the OTCQB market, not on NYSE/NASDAQ at this stage. For international investors, it should be viewed as a small-cap American company with a mixed profile: a legacy industrial/materials business built around natural rubber latex, alongside more recent strategic moves into digital finance and tokenization. Founded in 2001, Vystar initially developed its core thesis around Vytex®, an ultra-low-protein natural rubber latex designed to reduce antigenic and total proteins versus conventional latex. The company positions this technology as a cleaner raw material for products used in healthcare, consumer goods, adhesives, foams, textiles, coatings, and related applications. ([vystarcorp.com](https://vystarcorp.com/company-home/?utm_source=openai))
Vystar describes itself as the owner and manufacturer of multiple eco-friendly brands serving home, office, and medical markets. Its portfolio includes Vytex, as well as legacy operating assets such as Fluid Energy Conversion (FEC) and RXAIR. The company also highlights consumer-oriented uses of its technology, including bedding-related products such as mattresses, toppers, and pillows, which broadens the story beyond a pure industrial materials supplier. From a geographic standpoint, Vystar has historically emphasized international distribution and partnerships, including reach into North America and Europe, and references a global footprint for some of its latex-related products. ([vystarcorp.com](https://vystarcorp.com/company-home/?utm_source=openai))
Read moreShow less
On competitive positioning, Vystar is best understood as a niche specialty player rather than a scale leader. Its potential moat rests on product differentiation: Vytex is presented as a technically improved natural latex alternative with lower protein content and reduced impurity levels, which may be relevant in sensitive use cases such as medical and hygiene products. However, the company operates in markets where larger, better-capitalized competitors dominate procurement, distribution, manufacturing, and branding. As a result, the investment case is less about current market share and more about whether Vystar can monetize its intellectual property and niche brand portfolio in a sustainable way. ([vystarcorp.com](https://vystarcorp.com/company-home/?utm_source=openai))
Recent developments point to a more pronounced strategic pivot. In April 2026, Vystar announced a binding letter of intent to acquire a 50% interest in R3alm, a compliance-focused AI/Web3 financial ecosystem centered on tokenized assets, digital capital formation, and trading infrastructure. Shortly afterward, Vystar said it was concentrating most of its resources on R3alm while also planning a dividend spin-off of RXAIR and related brands. That sequence suggests a company in transition, balancing industrial legacy assets with a higher-risk fintech and digital-asset initiative. For investors, the key takeaway is that Vystar remains an evolving U.S. micro-cap story with exposure to materials, healthcare-adjacent products, consumer brands, and emerging digital finance themes, all within the United States-listed market structure. ([globenewswire.com](https://www.globenewswire.com/news-release/2026/04/20/3277127/0/en/vystar-enters-into-binding-letter-of-intent-to-acquire-50-interest-in-r3alm-inc.html?utm_source=openai))
